Your browser doesn't support javascript.
loading
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.
Msaouel, Pavlos; Oromendia, Clara; Siefker-Radtke, Arlene O; Tannir, Nizar M; Subudhi, Sumit K; Gao, Jianjun; Wang, Yinghong; Siddiqui, Bilal A; Shah, Amishi Y; Aparicio, Ana M; Campbell, Matthew T; Zurita, Amado J; Shaw, Leah K; Lopez, Lidia P; McCord, Heather; Chakraborty, Sandip N; Perales, Jacqueline; Lu, Cong; Van Alstine, Michael L; Elashoff, Michael; Logothetis, Christopher.
Afiliação
  • Msaouel P; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Oromendia C; Division of Pathology and Laboratory Medicine, Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston.
  • Siefker-Radtke AO; The Ronin Project, San Mateo, California.
  • Tannir NM; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Subudhi SK; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Gao J; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Wang Y; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Siddiqui BA; Division of Internal Medicine, Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston.
  • Shah AY; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston.
  • Aparicio AM; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Campbell MT; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Zurita AJ; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Shaw LK; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Lopez LP; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • McCord H; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Chakraborty SN; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Perales J; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Lu C; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Van Alstine ML; The Ronin Project, San Mateo, California.
  • Elashoff M; The Ronin Project, San Mateo, California.
  • Logothetis C; The Ronin Project, San Mateo, California.
JAMA Netw Open ; 4(8): e2122998, 2021 08 02.
Article em En | MEDLINE | ID: mdl-34459906
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Urogenitais / Testes de Toxicidade / Aplicativos Móveis / Medidas de Resultados Relatados pelo Paciente / Monitoramento Biológico / Inibidores de Checkpoint Imunológico Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Urogenitais / Testes de Toxicidade / Aplicativos Móveis / Medidas de Resultados Relatados pelo Paciente / Monitoramento Biológico / Inibidores de Checkpoint Imunológico Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article